Today is Monday, Mar. 27, 2017

Department of

Department of Psychiatry and Behavioral Neuroscience

Fellowships Program

Research Mentoring

Addiction Psychiatry Fellows have available time towards their scholarly project, which can be research. Addiction Research-Medicine Fellows also have available time for a scholarly project, but have over half of their time protected for clinically-oriented research.

Fellows determine their area of interest and then are matched to practicing researchers within the department. All fellows receive formal didactic lectures on issues central to learning how to perform clinically-oriented research (ethics, IRB, statistics, etc.).

Today, UC Department of Psychiatry and the Cincinnati VAMC rank well in terms of research funding. We have particular strengths in the areas of addiction disorders, PTSD, eating disorders, and bipolar disorder. The department has one of the largest pharmaceutical research programs of any psychiatry department in the country. We have perhaps the largest NIDA Clinical Trials Node in the country as well.

Addiction Sciences Division faculty have a wealth and variety of research projects already in place and potentially available for fellow experiences:

  • Dr. Benoit: As Director of the Behavioral Assay Core in the Obesity Research Center, Dr. Benoit’s work focuses on neurobiological controls over behavior with emphases on food intake, reward and learning.
  • Dr. Chard: As Director of the PTSD divisions in both the VA and UC, Dr. Chard is an international leader in therapy approaches to PTSD.
  • Dr. Geracioti: Serving in a leadership role in the VA's Ofice of Research, Dr. Geracioti is an international leader in PTSD research, specifically cerebrospinal fluid studies of veterans.
  • Dr. Gudelsky: With funding support from NIDA, Dr. Gudelsky’s group studies the determinants and consequences of MDMA (”Ecstacy”) neurotoxicity. 
  • Dr. Herman: In his role as director of the Stress Neurobiology Program, Dr. Herman and colleagues (including ASD faculty member, Dr. Ulrich-Lai) examine the physiological actions of CNS stress circuits, stress hormone secretion, affective disease states and neuronal aging.
  • Dr. Hosta: Dr. Hosta has studied the relationship of methadone dose on treatment retention in pregnant and postpartum methadone patients.
  • Dr. Miller: In his role as a USAF Reservist and VA physician, Dr. Miller has worked with the United States Air Force Research Lab to conduct analyses of survey data relating to addiction-related disorders as well as general psychiatric disorders such as PTSD and mild TBI in OIF/OEF. Dr. Miller has successfully competed (as mentor),  together with his fellows, to earn 2 NIDA-ABAM Research in Addiction Medicine Scholar Awards.
  • Dr. Norman: NIDA-funded projects conducted by Dr. Norman and associates have focused on developing a human antibody as an immunotheraphy for cocaine abuse along with other novel therapeutic agents for cocaine addiction.
  • Dr. Plott: A graduate of the NIDA-ABAM Research in Addiction Medicine Program, Dr. Plott performs research studying risk for addiction in chronic opioid therapy for pain.
  • Dr. Schumm:  Dr. Schumm's NIDA-funded research includes Behavioral Couples Therapy for addiction disorders.
  • Dr. Vorhees: NIDA-funded reserach projects being conducted by Dr. Vorhees and colleagues are investigating HPA axis mechanisms involed in learning and memory deficits induced by developmental methampheamine exposure and the effects of neonatal MDMA exposure on learning and memory.
  • Dr. Wilder: Dr. Wilder is a graduate of the NIDA-ABA Research in Addiction Medicine Scholars Program. With local and VA funding support, Dr. Wilder’s research focuses on prevention of the adverse effects of opioid use disorder, including prevention of opioid overdose and medication assisted treatment maintenance in pregnant and postpartum women.
  • Dr. Winhusen: As part of the NIDA Clinical Trials Network, Dr. Winhusen's research focuses primarily on developing new psychotherapies for cocaine, methamphetamine, and prescription opioid addiction. This has included work on pregnant substance abusing women. Dr. Winhusen has been recognized as a leader in clinical trials delivery by NIDA with the Besteman Award given by NIDA Director Nora Volkow.
  • Dr. Winstanley: As the Director of Health Services Research at Mercy Health, Dr. Winstanley's focus is to develop interventions to reduce the morbidity and mortality of opioid misuse and dependence. She is considered an expert in addiction health services and has recieved federal and local grants .
  • Dr. Woods: Although primarily known for his pioneering work in the obesity field, Dr. Woods and colleagues have also investigated the role of neuropeptides in regulating alcohol reward processing.

 

Supporting research entities that may be of interest to addiction fellows include: